MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation GERN today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at the following investor conferences:
- Stifel 2018 Healthcare Conference in New York at 2:00 p.m. ET on Wednesday, November 14, 2018
- 30th Annual Piper Jaffray Healthcare Conference in New York at 11:30 a.m. ET on Tuesday, November 27, 2018
A live audio webcast of each presentation will be available on Geron's website, www.geron.com/investors/events. If you are unable to listen to the live presentations, an archived webcast of each presentation will be available on the Company's website for 30 days.
About Geron
Geron is a clinical stage biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.
CONTACT:
Suzanne Messere
Investor and Media Relations
investor@geron.com
media@geron.com
CG Capital
877-889-1972
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.